118.32
price up icon0.42%   0.50
after-market Dopo l'orario di chiusura: 118.32
loading
Precedente Chiudi:
$117.82
Aprire:
$118.54
Volume 24 ore:
1.12M
Relative Volume:
1.39
Capitalizzazione di mercato:
$6.67B
Reddito:
$738.26M
Utile/perdita netta:
$48.89M
Rapporto P/E:
136.87
EPS:
0.8645
Flusso di cassa netto:
$91.69M
1 W Prestazione:
+3.50%
1M Prestazione:
-8.09%
6M Prestazione:
-18.85%
1 anno Prestazione:
-7.92%
Intervallo 1D:
Value
$117.83
$120.90
Intervallo di 1 settimana:
Value
$109.66
$120.90
Portata 52W:
Value
$102.97
$175.77

Repligen Corp Stock (RGEN) Company Profile

Name
Nome
Repligen Corp
Name
Telefono
(781) 449-9560
Name
Indirizzo
41 SEYON STREET, WALTHAM, MA
Name
Dipendente
2,000
Name
Cinguettio
@repligen
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
RGEN's Discussions on Twitter

Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
RGEN icon
RGEN
Repligen Corp
118.32 6.64B 738.26M 48.89M 91.69M 0.8645
ISRG icon
ISRG
Intuitive Surgical Inc
464.45 163.73B 10.06B 2.88B 2.49B 7.876
BDX icon
BDX
Becton Dickinson Co
156.34 44.73B 21.92B 1.76B 2.63B 6.1223
ALC icon
ALC
Alcon Inc
75.51 36.73B 10.40B 980.00M 1.61B 1.9749
MDLN icon
MDLN
Medline Inc
44.00 36.12B 28.43B 1.16B 1.26B 1.4457
RMD icon
RMD
Resmed Inc
222.85 32.70B 5.40B 1.49B 1.78B 10.12

Repligen Corp Stock (RGEN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-01 Iniziato HSBC Securities Buy
2025-09-22 Aggiornamento Evercore ISI In-line → Outperform
2025-07-22 Ripresa Stephens Overweight
2025-06-24 Iniziato Barclays Overweight
2025-04-29 Aggiornamento Wolfe Research Peer Perform → Outperform
2025-03-18 Iniziato Evercore ISI In-line
2025-02-10 Iniziato TD Cowen Buy
2024-12-17 Iniziato Canaccord Genuity Hold
2024-11-14 Iniziato Wolfe Research Peer Perform
2024-08-28 Iniziato Wells Fargo Overweight
2024-06-26 Aggiornamento Deutsche Bank Hold → Buy
2024-06-18 Iniziato Guggenheim Neutral
2023-12-04 Downgrade The Benchmark Company Buy → Hold
2023-07-20 Iniziato Wells Fargo Overweight
2023-07-05 Ripresa JP Morgan Overweight
2023-03-28 Iniziato The Benchmark Company Buy
2022-12-14 Iniziato Deutsche Bank Hold
2022-12-07 Iniziato RBC Capital Mkts Sector Perform
2022-07-20 Iniziato UBS Buy
2021-10-14 Iniziato Exane BNP Paribas Outperform
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-08-24 Reiterato H.C. Wainwright Buy
2020-06-30 Reiterato H.C. Wainwright Buy
2020-05-07 Reiterato H.C. Wainwright Buy
2020-03-23 Reiterato H.C. Wainwright Buy
2019-11-15 Iniziato Stifel Buy
2019-11-01 Aggiornamento First Analysis Sec Outperform → Strong Buy
2019-10-15 Iniziato SVB Leerink Outperform
2019-08-28 Reiterato First Analysis Sec Outperform
2019-08-23 Ripresa Stephens Overweight
2019-07-22 Aggiornamento H.C. Wainwright Neutral → Buy
2018-12-17 Aggiornamento CL King Neutral → Buy
2018-11-12 Downgrade CL King Buy → Neutral
2018-09-26 Iniziato H.C. Wainwright Neutral
2017-12-08 Iniziato Citigroup Buy
2017-12-05 Iniziato JP Morgan Overweight
2017-11-13 Iniziato CL King Buy
2017-10-02 Aggiornamento First Analysis Sec Equal-Weight → Overweight
2017-07-21 Iniziato William Blair Outperform
2017-02-13 Aggiornamento Piper Jaffray Neutral → Overweight
Mostra tutto

Repligen Corp Borsa (RGEN) Ultime notizie

pulisher
04:12 AM

Are Options Investors Anticipating Significant Movement in Repligen Shares? - bitget.com

04:12 AM
pulisher
03:03 AM

Are Options Traders Betting on a Big Move in Repligen Stock? - Yahoo Finance

03:03 AM
pulisher
Mar 31, 2026

Will Repligen Corporation face regulatory challenges2026 Intraday Action & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 30, 2026

Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart - Capital.com

Mar 30, 2026
pulisher
Mar 30, 2026

Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com

Mar 30, 2026
pulisher
Mar 28, 2026

Repligen Corp Stock: Bioprocessing Leader with Strong Growth in Biopharma Supply Chain - AD HOC NEWS

Mar 28, 2026
pulisher
Mar 27, 2026

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard amends Schedule 13G/A for Repligen (RGEN): reports 0 shares - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 26, 2026
pulisher
Mar 26, 2026

RGEN PE Ratio & Valuation, Is RGEN Overvalued - Intellectia AI

Mar 26, 2026
pulisher
Mar 24, 2026

E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat

Mar 24, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan

Mar 23, 2026
pulisher
Mar 23, 2026

RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus

Mar 23, 2026
pulisher
Mar 23, 2026

H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada

Mar 23, 2026
pulisher
Mar 23, 2026

H.C. Wainwright raises Repligen stock price target on strong growth - Investing.com

Mar 23, 2026
pulisher
Mar 23, 2026

Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat

Mar 23, 2026
pulisher
Mar 22, 2026

Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat

Mar 22, 2026
pulisher
Mar 21, 2026

Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance

Mar 21, 2026
pulisher
Mar 21, 2026

Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 21, 2026

Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS

Mar 21, 2026
pulisher
Mar 19, 2026

Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance

Mar 19, 2026
pulisher
Mar 17, 2026

Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 17, 2026
pulisher
Mar 16, 2026

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance

Mar 16, 2026
pulisher
Mar 16, 2026

270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat

Mar 16, 2026
pulisher
Mar 11, 2026

Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus

Mar 11, 2026
pulisher
Mar 10, 2026

Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com

Mar 10, 2026
pulisher
Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance

Mar 08, 2026
pulisher
Mar 08, 2026

Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance

Mar 08, 2026
pulisher
Mar 08, 2026

Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st

Mar 08, 2026
pulisher
Mar 08, 2026

Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn

Mar 08, 2026
pulisher
Mar 06, 2026

AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 06, 2026
pulisher
Mar 05, 2026

Repligen Corporation to Present at Upcoming March Conferences - ChartMill

Mar 05, 2026
pulisher
Mar 04, 2026

RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Repligen Corporation $RGEN Shares Sold by TD Asset Management Inc - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

NZS Capital LLC Has $26.30 Million Stake in Repligen Corporation $RGEN - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) COO uses 3,911 shares to cover tax withholding - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CEO reports tax-withholding share dispositions in Form 4 - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) director uses 9,897 shares to cover RSU taxes - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CFO stock withheld to cover RSU tax obligations - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) SVP uses company shares to cover RSU taxes - Stock Titan

Mar 03, 2026
pulisher
Mar 03, 2026

Repligen (RGEN) CPO has shares withheld to cover RSU tax bill - Stock Titan

Mar 03, 2026
pulisher
Mar 02, 2026

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector - DirectorsTalk Interviews

Mar 02, 2026
pulisher
Mar 02, 2026

Repligen Corporation $RGEN Position Boosted by Royce & Associates LP - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

Artisan Partners Limited Partnership Has $28.44 Million Stock Holdings in Repligen Corporation $RGEN - MarketBeat

Mar 01, 2026

Repligen Corp Azioni (RGEN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$64.35
price down icon 1.45%
$172.73
price up icon 0.76%
COO COO
$71.43
price down icon 0.10%
$75.60
price up icon 0.01%
WST WST
$252.74
price up icon 0.84%
RMD RMD
$222.85
price down icon 0.73%
Capitalizzazione:     |  Volume (24 ore):